How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,310 results for

Occlusive Dressing

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

21. Toxic Tacrolimus Levels After Application of Topical Tacrolimus and Use of Occlusive Dressings in Two Bone Marrow Transplant Recipients with Cutaneous Graft-versus-Host Disease. (PubMed)

Toxic Tacrolimus Levels After Application of Topical Tacrolimus and Use of Occlusive Dressings in Two Bone Marrow Transplant Recipients with Cutaneous Graft-versus-Host Disease. Tacrolimus, a macrolide immunosuppressant, is used topically for the treatment of cutaneous manifestations of graft-versus-host disease (GVHD) for rapid, symptomatic relief of pruritus and erythema. Despite the manufacturer's product information reporting minimal systemic effects of topical tacrolimus, this has not been (...) evaluated in patients with cutaneous GVHD and with occlusive dressings. We describe two patients with cutaneous GVHD who developed toxic tacrolimus levels after receiving several applications of tacrolimus ointment along with occlusive dressings to enhance skin effectiveness. The first patient was a 62-year-old woman with a history of acute myelogenous leukemia (AML) who underwent allogeneic bone marrow transplantation and developed chronic GVHD involving 70% of her body surface area. Her GVHD treatment

2014 Pharmacotherapy

22. The healing effect of over-the-counter (OTC) wound healing agents applied under semi-occlusive film dressing. (PubMed)

The healing effect of over-the-counter (OTC) wound healing agents applied under semi-occlusive film dressing. 25059458 2015 11 10 2015 02 09 1365-2133 172 2 2015 Feb The British journal of dermatology Br. J. Dermatol. The healing effect of over-the-counter wound healing agents applied under semiocclusive film dressing. 544-6 10.1111/bjd.13289 Davis S C SC University of Miami Miller School of Medicine, Miami, FL, U.S.A. sdavis@med.miami.edu. Gil J J Treu R R Valdes J J Solis M M Eberlein T T (...) Eaglstein W H WH eng Letter Research Support, Non-U.S. Gov't 2015 01 13 England Br J Dermatol 0004041 0007-0963 0 Dermatologic Agents 0 Drug Combinations 0 Nonprescription Drugs 0 Ointments IM Administration, Cutaneous Animals Dermatologic Agents administration & dosage pharmacology Drug Combinations Female Nonprescription Drugs administration & dosage pharmacology Occlusive Dressings Ointments Skin injuries Wound Healing drug effects 2014 7 26 6 0 2014 7 26 6 0 2015 11 11 6 0 ppublish 25059458 10.1111

2014 British Journal of Dermatology

23. Open-label randomized controlled trial to compare wound dressings for patients undergoing hip and knee arthroplasty: study protocol for a randomized controlled trial (PubMed)

Open-label randomized controlled trial to compare wound dressings for patients undergoing hip and knee arthroplasty: study protocol for a randomized controlled trial Surgical wounds are covered to prevent bleeding, absorb the exudates, and provide a barrier against external contamination. Currently, in our hospital, after orthopedic surgery, traditional occlusive dressing of sterile gauze and non-woven hypoallergenic adhesive tape is placed. Some of the newest dressings have been shown (...) occlusive dressing, (2) Aquacel Surgical®, (3) Mepilex® Border Post-Op, (4) OpSite Post-Op Visible, or (5) UrgoTul® Absorb Border. The dressing assigned is placed right after surgery. Patients will be followed up to 14 days after surgery when the dressing is definitively removed and will be tracked up to 3 months to record any late complications. During the immediate postoperative period and patient hospitalization and at the ambulatory visits after discharge, every time that the dressing is changed

Full Text available with Trip Pro

2018 Trials

24. Negative Pressure Wound Therapy vs. Sterile Dressing for Patients Undergoing Thoracolumbar Spine Surgery

Sterile Dressing in Patients Undergoing Thoracolumbar Posterior Spine Surgery Actual Study Start Date : March 18, 2017 Estimated Primary Completion Date : August 2020 Estimated Study Completion Date : August 2020 Resource links provided by the National Library of Medicine related topics: Arms and Interventions Go to Arm Intervention/treatment Sterile Dressing Standard of care treatment - Standard wound care involves the application of an occlusive dressing in the operating room, a dressing change (...) on Post-operative Day 3 and then dressing changes as needed until suture/staple removal on Post-operative Day 14. Other: Sterile dressing Standard wound care involves the application of an occlusive dressing in the operating room, a dressing change on Post-operative Day 3 and then dressing changes as needed until suture/staple removal on Post-operative Day 14. Active Comparator: Vacuum Assisted Closure The Prevena™ System, a type of vacuum assisted closure, is indicated for use over clean, closed

2018 Clinical Trials

25. Usefulness of Sterile Adhesive Dressing at the Exit-site of Peritoneal Dialysis Catheter

from the Registry of Peritoneal Dialysis of French Language. The number of patients included from the register can not be fixed in advance; this number will correspond to the 4-year follow-up at the start date of the study to ensure at least two years of patient follow-up Usually care First dressing 5 or 10 days after the pose of the catheter : Cleaning emergence with antiseptic soap Rinsing with saline Drying Application of a hazelnut mupirocin on the exit-site Application of an occlusive dressing (...) on the exit-site Then, care is the same. Exit-site care is performed daily if the patient takes a shower or twice a week. Experimental: No dressing No application of sterile dressing at the exit-site of periotoneal dialysis catheter for all patients (30 days after the placement of the peritoneal dialysis catheter) Other: No dressing Then, care is the same and exit-site remains covered with an occlusive dressing to promote tunnel epithelialization and healing. The shower is forbidden during this period

2018 Clinical Trials

26. Needle-Aspirated Compression Dressing Following Ostomy Reversal

Closed Ileostomy and Colostomy Reversal Wounds? Actual Study Start Date : August 27, 2017 Estimated Primary Completion Date : August 1, 2019 Estimated Study Completion Date : August 1, 2019 Resource links provided by the National Library of Medicine related topics: Arms and Interventions Go to Arm Intervention/treatment Control primary closure with gauze and adhesive/occlusive dressing Procedure: Control dressing consisting of gauze and adhesive/occlusive dressing, placed over wound after primary (...) closure Experimental: Negative Pressure primary closure with gauze and adhesive/occlusive dressing under negative pressure Procedure: Needle-Aspirated Negative Pressure Dressing dressing consisting of Needle-Aspirated Negative Pressure dressing with gauze and adhesive/occlusive dressing, placed over wound after primary closure Outcome Measures Go to Primary Outcome Measures : Surgical Site Infection [ Time Frame: 30 days post procedure ] Surgical Site Infection Secondary Outcome Measures : Rate

2018 Clinical Trials

27. Effect of Vitamin E-containing Dressing on Surgical Site Infection in Colorectal Surgery

: Double (Participant, Outcomes Assessor) Primary Purpose: Prevention Official Title: Effecto of Total Occlusive Vitamin E-containing Dressing on Incisional Surgical Site Infection in Elective Laparoscopic Colorectal Surgery Actual Study Start Date : January 1, 2018 Estimated Primary Completion Date : March 30, 2018 Estimated Study Completion Date : March 30, 2018 Resource links provided by the National Library of Medicine related topics: available for: Arms and Interventions Go to Arm Intervention (...) Effect of Vitamin E-containing Dressing on Surgical Site Infection in Colorectal Surgery Effect of Vitamin E-containing Dressing on Surgical Site Infection in Colorectal Surgery - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies

2018 Clinical Trials

28. A novel integrated dressing to secure peripheral intravenous catheters in an adult acute hospital: a pilot randomised controlled trial (PubMed)

A novel integrated dressing to secure peripheral intravenous catheters in an adult acute hospital: a pilot randomised controlled trial The reported incidence of peripheral intravenous catheter (PIV) failure has been as high as 69%. This is in part due to inadequate stabilisation or securement to the skin, which allows micro-motion of the catheter within the vein.A pilot open randomised controlled trial of 300 patients was conducted in the medical and surgical wards of a large tertiary hospital (...) . A superiority parallel pragmatic design was used. Eligible patients over the age of 16 years were randomised using a centralised service (randomly varied block sizes and 1:1 ratio) to have PIV dressings of either (i) a bordered polyurethane dressing (BPU, standard care) or (ii) the integrated securement device (ISD). Allocation was concealed until entry. The primary outcome of feasibility addressed eligibility, consent, protocol adherence and retention rates. All-cause PIV failure was an additional primary

Full Text available with Trip Pro

2018 Trials

29. Effects of methods used to achieve hemostasis on radial artery occlusion following percutaneous coronary procedures: a systematic review. (PubMed)

Effects of methods used to achieve hemostasis on radial artery occlusion following percutaneous coronary procedures: a systematic review. Transradial access to percutaneous coronary procedures is becoming the preferred access route, and it is being increasingly used for emergent and elective procedures. However, radial artery occlusion (RAO) continues to remain an adverse occurrence following sheath removal or in the first 24 hours following sheath removal due to the smaller diameter (...) to prevent RAO.All randomized and quasi-randomized controlled trials evaluating the effect of various hemostatic methods on RAO rates after percutaneous coronary procedures were included in the review.The primary outcome of interest was the incidence of RAO at the time of discharge and persistent occlusion at the time of follow-up.The search aimed to find published and unpublished trials through electronic databases, reference lists and key reports. An extensive search was undertaken for the following

2017 JBI database of systematic reviews and implementation reports

30. Moist occlusive dressing (Aquacel(®) Ag) versus moist open dressing (MEBO(®)) in the management of partial-thickness facial burns: a comparative study in Ain Shams University. (PubMed)

Moist occlusive dressing (Aquacel(®) Ag) versus moist open dressing (MEBO(®)) in the management of partial-thickness facial burns: a comparative study in Ain Shams University. The face is the central point of the physical features; it transmits expressions and emotions, communicates feelings and allows for individual identity. Facial burns are very common and are devastating to the affected patient and results into numerous physical, emotional and psychosocial sequels. Partial thickness (...) -epithelialization was 10.5 days, while it was 12.4 days in the MEBO(®) group (p<0.05). Frequency of changes, pain and patient discomfort were less with Aquacel(®) Ag. Cost was of no significant difference between the two groups. Scar quality improved in the Aquacel(®) Ag treatment group. Three and 6 months follow-up was done and long-term outcomes were recorded in both groups.Moist occlusive dressing (Aquacel(®) Ag) significantly improves the management and healing rate of partial thickness facial burns

2012 Burns : journal of the International Society for Burn Injuries

31. Occlusive dressings and gauze dressings did not differ for healing open wounds in surgical patients

Occlusive dressings and gauze dressings did not differ for healing open wounds in surgical patients Occlusive dressings and gauze dressings did not differ for healing open wounds in surgical patientsCommentary | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal (...) accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Occlusive dressings and gauze dressings did not differ for healing open wounds in surgical patientsCommentary Article Text Treatment Occlusive dressings and gauze dressings did not differ

2009 Evidence-Based Nursing

32. Innovative dressing and securement of tunneled central venous access devices in pediatrics: a pilot randomized controlled trial. (PubMed)

). Dressing integrity, product costs and site complications were also examined.Protocol feasibility was established. CVAD failure was: 17% (2/12) integrated securement-dressing; 8% (1/13) suture-less securement device; 0% tissue adhesive (0/12); and, 0% standard care (0/11). CVAD complications were: 15% (2/13) suture-less securement device (CVAD associated bloodstream infection, and occlusion and partial dislodgement); 8% (1/12) integrated securement-dressing (partial dislodgement); 0% tissue adhesive (0 (...) Innovative dressing and securement of tunneled central venous access devices in pediatrics: a pilot randomized controlled trial. Central venous access device (CVAD) associated complications are a preventable source of patient harm, frequently resulting in morbidity and delays to vital treatment. Dressing and securement products are used to prevent infectious and mechanical complications, however current complication rates suggest customary practices are inadequate. The aim of this study

Full Text available with Trip Pro

2017 BMC Cancer

33. Peripherally InSerted CEntral catheter dressing and securement in patients with cancer: the PISCES trial. Protocol for a 2x2 factorial, superiority randomised controlled trial. (PubMed)

 years with allocation concealment until randomisation by a centralised service. For the dressing hypothesis, we hypothesise CHG discs will reduce catheter-associated bloodstream infection (CABSI) compared with no CHG disc. For the securement hypothesis, we hypothesise that ISD will reduce composite PICC failure (infection (CABSI/local infection), occlusion, dislodgement or thrombosis), compared with SED.types of PICC failure; safety; costs; dressing/securement failure; dwell time; microbial (...) Peripherally InSerted CEntral catheter dressing and securement in patients with cancer: the PISCES trial. Protocol for a 2x2 factorial, superiority randomised controlled trial. Around 30% of peripherally inserted central catheters (PICCs) fail from vascular, infectious or mechanical complications. Patients with cancer are at highest risk, and this increases morbidity, mortality and costs. Effective PICC dressing and securement may prevent PICC failure; however, no large randomised controlled

Full Text available with Trip Pro

2017 BMJ open

34. Use of Clorhexidine Dressings to Reduce Surgical Site Infections in Breast Cancer Surgery. A Controlled Clinical Trial

therapy and result increase morbidity and mortality. Also this increased costs associated with health care.Surgical drains have been noted as a potential source for surgical site infections. The primary aim of the study is to determine if chlorhexidine occlusive dressings applied to the intervention drain sites effectively decreases rates of bacterial colonization in drain fluid and drain tips compared to standard care. Condition or disease Intervention/treatment Phase Breast Cancer Device: Antiseptic (...) occlusive dressing group Not Applicable Detailed Description: Following approval by the National Cancer Institute Review Board, eligible subjects will be recruited prospectively from the Breast Cancer Department at National Cancer Institute, México from November 2016 to November 2017. Individuals with confirmed cancer undergoing total mastectomy (TM), modified radical mastectomy (MRM) and/or axillary lymph node dissection (ALND) in which surgical drains are going to be used will be identified through

2017 Clinical Trials

35. Antimicrobial Barrier Dressing Versus Closed-incision Negative Pressure Therapy in the Obese Primary Total Joint Arthroplasty

for details. ClinicalTrials.gov Identifier: NCT03345771 Recruitment Status : Recruiting First Posted : November 17, 2017 Last Update Posted : November 8, 2018 See Sponsor: New York University School of Medicine Information provided by (Responsible Party): New York University School of Medicine Study Details Study Description Go to Brief Summary: The purpose of this study is to determine whether an occlusive antimicrobial barrier dressing or portable negative pressure wound dressing is superior (...) Antimicrobial Barrier Dressing Versus Closed-incision Negative Pressure Therapy in the Obese Primary Total Joint Arthroplasty Antimicrobial Barrier Dressing Versus Closed-incision Negative Pressure Therapy in the Obese Primary Total Joint Arthroplasty - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached

2017 Clinical Trials

36. The Role of Antimicrobial Foam Dressing in Prevention of Cesarean Section Wound Complications

: None (Open Label) Primary Purpose: Prevention Official Title: The Role of Adherent Occlusive Antimicrobial Absorbent Foam Dressing in Prevention of Cesarean Section Wound Complications Actual Study Start Date : July 24, 2017 Estimated Primary Completion Date : June 2019 Estimated Study Completion Date : December 2019 Resource links provided by the National Library of Medicine related topics: Arms and Interventions Go to Arm Intervention/treatment Experimental: Silver-impregnated antimicrobial (...) dressing All participants undergoing primary cesarean section will receive a silver impregnated antimicrobial wound dressing (Mepilex Border AG), postoperative. Device: Silver-impregnated antimicrobial dressing All participants will receive an adherent soft silicone silver impregnated anti-microbial occlusive foam dressing after cesarean section. The dressing will stay on for up to seven days. Other Name: Mepilex Border AG Outcome Measures Go to Primary Outcome Measures : Wound complication rate [ Time

2017 Clinical Trials

37. Wich is the Best Dressing in Wounds by Primary Surgery of THA and / or TKA?

See Sponsor: Corporacion Parc Tauli Collaborators: Fundació Parc Taulí Department of Health, Generalitat de Catalunya Information provided by (Responsible Party): Maria Lopez-Parra, Corporacion Parc Tauli Study Details Study Description Go to Brief Summary: Surgical wounds are covered to prevent bleeding, absorb the exudates and provide a barrier against external contamination. Currently, in Corporació PT after orthopedic surgery, traditional occlusive dressing of sterile gauze and non-woven (...) in total knee and hip arthroplasty surgical wounds (TKA and THA). Secondary Objectives: To identify the dressing that provides greater advantages and minor inconveniences in TKA and THA surgery. Study population: Patients older than 18 years undergoing fast track primary TKA or THA. 110 patients Condition or disease Intervention/treatment Phase Occlusive Dressings Nursing Knee Surgery Hip Surgery Device: Aquacel Surgical® Device: Mepilex Border post-op® Device: Opsite post-op visible® Device: Urgotul

2017 Clinical Trials

38. A Prospective, Randomized, Comparative Study to Assess the Prevention of Surgical Site Infection (SSI's) in Revision Total Joint Arthroplasty Patients Treated With Single-Use Negative Pressure Wound Therapy (PICO) or Standard Care Dressings (AQUACEL Ag SU

by the National Library of Medicine related topics: Arms and Interventions Go to Arm Intervention/treatment Active Comparator: Single-Use Negative Pressure Wound Therapy Device: PICO Single Use Negative Pressure Dressing Active Comparator: Standard of Care Device: Aquacel Occlusive surgical dressing infused with ionized silver Outcome Measures Go to Primary Outcome Measures : Surgical Site Infection [ Time Frame: 90-day followup following revision surgery ] Eligibility Criteria Go to Information from (...) A Prospective, Randomized, Comparative Study to Assess the Prevention of Surgical Site Infection (SSI's) in Revision Total Joint Arthroplasty Patients Treated With Single-Use Negative Pressure Wound Therapy (PICO) or Standard Care Dressings (AQUACEL Ag SU A Prospective, Randomized, Comparative Study to Assess the Prevention of Surgical Site Infection (SSI's) in Revision Total Joint Arthroplasty Patients Treated With Single-Use Negative Pressure Wound Therapy (PICO) or Standard Care Dressings

2017 Clinical Trials

39. Central venous Access device SeCurement And Dressing Effectiveness for peripherally inserted central catheters in adult acute hospital patients (CASCADE): a pilot randomised controlled trial (PubMed)

a chlorhexidine-gluconate (CHG) impregnated disc. Feasibility outcomes were recruitment and safety/acceptability of the interventions. The primary outcome was PICC failure, a composite of PICC removal for local infection, catheter-associated bloodstream infection, dislodgement, occlusion, and/or catheter fracture. Secondary outcomes included individual complications, dressing failure and dwell time, PICC dwell time, skin complications/phlebitis indicators, product costs, and patient and staff satisfaction (...) Central venous Access device SeCurement And Dressing Effectiveness for peripherally inserted central catheters in adult acute hospital patients (CASCADE): a pilot randomised controlled trial Peripherally inserted central catheters (PICCs) are commonly used for delivering intravenous therapy. PICC failure is unacceptably high (up to 40%) due to mechanical, infectious and thrombotic complications. Poor securement potentiates all complication types. This randomised controlled trial (RCT) aimed

Full Text available with Trip Pro

2017 Trials

40. Glycosaminoglycan hydrogels as supplemental wound dressings for donor sites. (PubMed)

Glycosaminoglycan hydrogels as supplemental wound dressings for donor sites. Chemically crosslinked glycosaminoglycan (GAG) hydrogel films were evaluated as biointeractive dressings in a porcine model for donor-site autograft wounds. Multiple 5 x 5 x 0.03 cm wounds were created on the dorsum of pigs. Half of the wounds were treated with a GAG film plus an occlusive dressing (Tegaderm), whereas the other half were treated with Tegaderm alone. At 3, 5, or 7 days after surgery, the partially (...) healed wounds were excised and evaluated histologically for three animals at each time point. By day 3, epithelial cells had proliferated and migrated from wound edges and from epithelial islands associated with residual hair follicles to begin to cover the wound bed. A statistically significant increase in coverage was observed for GAG + Tegaderm-dressed wounds than for those with Tegaderm alone at day 3 and day 5 post-surgery. By day 7, all treatment groups were completely healed. Thus, GAG

2017 Journal of Burn Care & Rehabilitation

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>